Stock Options“Infusion Biosciences will contribute up to six of its key personnel to lead and assist in the day-to-day operations of Sproutly.”
Maybe those stock options were given to these six individuals that came over from IBS. If so, that’s certainly a little extra incentive to produce. That’s why I don’t see bankruptcy.
Also it appears that IBS generates most there revenue from there US partners (US rights) that these individuals were able to acquire. And it seems as though Sen has a lot of confidence their ability. IBS is Sproutly’s largest share holder with Sen’s life’s work and legacy is at stake. He’s not a young man and doesn’t have time to waste. This is perhaps the reasoning behind the $2 million infusion and the not so hostile take over.
So he has all the power now. The cash, the technology, the team, the patent, the confidence in his superior tech, and now the captains chair. So it’s all up to him.
If he just wants to, one positive NR from him will send this stock rocketing!